|
|
|
Insider
Information: |
Henderson Michael Thomas |
Relationship: |
Chief Executive Office... |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,668,698 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$87,648,711 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,668,698 |
|
|
Total
Value |
$87,648,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bridgebio Pharma, Inc. |
BBIO |
Chief Business Officer |
2020-12-01 |
274,211 |
2019-07-01 |
0 |
Premium* |
|
Apogee Therapeutics, Inc. |
APGE |
Chief Executive Office... |
2024-09-04 |
1,394,487 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
|
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
173,767 |
173,767 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
83,541 |
245,903 |
0 |
- |
|
APGE |
Apogee Therapeutics, Inc. |
Chief Executive Officer |
|
2024-08-07 |
4 |
AS |
$40.40 |
$1,624,764 |
D/D |
(40,000) |
1,434,487 |
0 |
% |
|
APGE |
Apogee Therapeutics, Inc. |
Chief Executive Officer |
|
2024-09-04 |
4 |
AS |
$47.28 |
$1,904,841 |
D/D |
(40,000) |
1,394,487 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-11-16 |
4 |
OE |
$0.00 |
$10,500 |
D/D |
22,813 |
280,564 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-05-26 |
4 |
OE |
$1.05 |
$19,283 |
D/D |
18,365 |
264,268 |
0 |
- |
|
APGE |
Apogee Therapeutics, Inc. |
Chief Executive Officer |
|
2024-07-05 |
4 |
AS |
$37.26 |
$558,900 |
D/D |
(15,000) |
1,474,487 |
0 |
% |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,812 |
273,211 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-07-01 |
4 |
OE |
$0.16 |
$1,600 |
D/D |
10,000 |
270,293 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-07-01 |
4 |
AS |
$30.63 |
$309,701 |
D/D |
(10,000) |
260,293 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-08-03 |
4 |
OE |
$0.16 |
$1,600 |
D/D |
10,000 |
270,293 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-08-03 |
4 |
AS |
$27.28 |
$273,741 |
D/D |
(10,000) |
260,293 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-09-01 |
4 |
OE |
$0.16 |
$1,600 |
D/D |
10,000 |
277,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-09-01 |
4 |
AS |
$27.89 |
$287,334 |
D/D |
(10,000) |
267,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-09-18 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
267,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-09-18 |
4 |
OE |
$0.16 |
$2,212 |
D/D |
10,000 |
277,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-10-01 |
4 |
OE |
$0.28 |
$7,994 |
D/D |
10,000 |
277,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-10-01 |
4 |
AS |
$38.29 |
$388,342 |
D/D |
(10,000) |
267,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-11-02 |
4 |
OE |
$1.05 |
$10,500 |
D/D |
10,000 |
277,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-11-02 |
4 |
AS |
$38.33 |
$383,558 |
D/D |
(10,000) |
267,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-11-16 |
4 |
AS |
$45.00 |
$450,000 |
D/D |
(10,000) |
267,751 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-12-01 |
4 |
AS |
$51.12 |
$515,204 |
D/D |
(10,000) |
274,211 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-12-01 |
4 |
OE |
$1.05 |
$10,500 |
D/D |
10,000 |
284,211 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
|
2019-07-01 |
4 |
B |
$17.00 |
$119,000 |
D/D |
7,000 |
180,767 |
2.74 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Chief Business Officer |
|
2020-11-16 |
4 |
D |
$44.33 |
$281,628 |
D/D |
(6,353) |
274,211 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|